Bharat Biotech on Saturday received approval for emergency use authorisation of the Covaxin Covid-19 vaccine for children in the 12-18 years age group by the Drug Controller General of India (DGCI), said authorities.
Covaxin is now the second vaccine cleared for use for children in India. In August, The Drugs Controller General of India (DCGI) gave approval for emergency-use authorization of Zydus Cadila’s ZyCoV-D vaccine, the Union Ministry of Science and Technology said. The world’s first and India’s indigenously developed DNA-based vaccine for COVID-19 will be administered in humans including children and adults 12 years and above, the ministry
By Joseph Maliakan As a reporter who has witnessed the continuous erosion of academic freedoms…
KOCHI: The significance of the Comprehensive Economic Partnership Agreement (CEPA) as a catalyst to boost…
Kochi: A business seminar aimed at providing exporters and the business community with insights into…
The International Chamber for Indian Music & Culture, an international initiatives of Parakkadathu Koyickal Trust,…
India Union Budget was sector diversified and considering the increasing global economic challenges, the India…
MUSCAT: The ‘Who’s Who of Oman Indian s’, which will include detailed information on prominent…
This website uses cookies.